ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PACB Pacific Biosciences of California Inc

1.46
0.08 (5.80%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Pacific Biosciences of California Inc NASDAQ:PACB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.08 5.80% 1.46 1.44 1.48 1.5395 1.36 1.4499 7,986,911 00:58:14

Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call

21/01/2020 7:16pm

GlobeNewswire Inc.


Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Pacific Biosciences of C... Charts.

Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Fourth Quarter 2019 Financial Results on Thursday, February 6, 2020, at 4:30pm Eastern Time. The Company will be sharing its plans for 2020 during the conference call.

The call will be webcast and may be accessed at Pacific Biosciences’ website at:  http://investor.pacificbiosciences.com/.

Date: January 6, 2020

Time: 4:30pm ET

Listen via Internet: http://investor.pacificbiosciences.com/

Toll-free: 888.366.7247

International: 707.287.9330

Conference ID: 7968618

Replay: http://investor.pacificbiosciences.com

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.

Contact:  Pacific Biosciences

Trevin Rard650.521.8450ir@pacificbiosciences.com

1 Year Pacific Biosciences of C... Chart

1 Year Pacific Biosciences of C... Chart

1 Month Pacific Biosciences of C... Chart

1 Month Pacific Biosciences of C... Chart

Your Recent History

Delayed Upgrade Clock